CompletedNot Applicable

The Glucose Transporter Type I Deficiency (G1D) Registry

United States471 participantsStarted 2013-12

Plain-language summary

The purpose of this protocol is to create a registry for patients diagnosed with Glucose Transporter Type 1 Deficiency (G1D), or patients experiencing symptoms consistent with G1D but not yet diagnosed, to enter medical information for physicians and other health researchers to analyze to increase the understanding of G1D and any sub-diagnoses.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Males and females * G1D diagnosis * Patients experiencing symptoms of G1D but who have not yet received a diagnosis Exclusion Criteria: * Patients who are not experiencing any symptoms of G1D

What they're measuring

Symptom Severity

Timeframe: 5 years

Trial details

NCT IDNCT02013583

SponsorUniversity of Texas Southwestern Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-08-01

View on ClinicalTrials.gov More GLUT1 Deficiency Syndrome trials